{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:30:29Z","timestamp":1780374629835,"version":"3.54.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The coronary slow flow\/no-reflow phenomenon (CSF\/NRP) is a common complication of emergency percutaneous coronary intervention (PCI) for ST-elevated myocardial infarction (STEMI). Its long-term prognostic value, however, remains unclear. This study investigated the long-term outcome and prognostic value of CSF\/NRP after emergency PCI for STEMI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective, multicenter registry-based cohort study was conducted in STEMI patients who underwent emergency PCI between 2015 and 2016. Incidence of in-hospital mortality, major adverse cardiac and cerebrovascular events (MACCEs), and all-cause mortality during long-term follow-up were compared between CSF\/NRP patients and the normal flow group. Cox proportional-hazards regression model was performed to identify the predictive impact of CSF\/NRP in short- and long-term outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 649 STEMI patients were included in the study, of whom 193 (29.7%) developed CSF\/NRP following emergency PCI. The CSF\/NRP group had a higher incidence of in-hospital mortality than the non-CSF\/NRP group (8.2 vs. 4.3%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.04). All-cause mortality incidence was also higher in the CSF\/NRP group during 5-year follow-up (22.2 vs. 16.2%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.04). The Cox proportional hazards model adjusting for demographic and clinical variables identified the NRP as an independent predictor of 5-year cardiac mortality [hazard ratio: 1.89; 95% confidence interval (CI): 1.07\u20133.31; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.02]. In a landmark analysis, no difference was seen in overall mortality among the two study groups between 1\u2005month and 5-year follow-up (hazard ratio: 1.33; 95% CI: 0.80\u20132.21, <jats:italic toggle=\"yes\">P<\/jats:italic>-value: 0.23). Kaplan\u2013Meier analysis showed lower 3-year cumulative MACCE-free survival in the CSF\/NRP group compared with the normal flow group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.02).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>CSF\/NRP in STEMI patients is associated with a worse short- and long-term prognosis. These results, however, are mostly related to the acute phase, and CSF\/NRP had limited influence on clinical outcomes in early survivors of STEMI.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mca.0000000000001362","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T09:32:27Z","timestamp":1712050347000},"page":"389-396","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Long-term outcome and prognostic value of angiographic slow\/no-reflow phenomenon after emergency percutaneous coronary intervention for ST-elevation myocardial infarction"],"prefix":"10.1097","volume":"35","author":[{"given":"Atefeh","family":"Bamarinejad","sequence":"first","affiliation":[{"name":"Isfahan Cardiovascular Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Kermani-Alghoraishi","sequence":"additional","affiliation":[{"name":"Interventional Cardiology Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azam","family":"Soleimani","sequence":"additional","affiliation":[{"name":"Heart Failure Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Roohafza","sequence":"additional","affiliation":[{"name":"Isfahan Cardiovascular Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safoura","family":"Yazdekhasti","sequence":"additional","affiliation":[{"name":"Cardiac Rehabilitation Research Center, Cardiovascular Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"MirmohammadSadeghi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chamran Cardiovascular Medical and Research Hospital, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Bamarinejad","sequence":"additional","affiliation":[{"name":"Isfahan Cardiovascular Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Sadeghi","sequence":"additional","affiliation":[{"name":"Cardiac Rehabilitation Research Center, Cardiovascular Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,4,2]]},"reference":[{"key":"R2-20250729","first-page":"100044","article-title":"STEMI care 2021: addressing the knowledge gaps.","volume":"11","author":"Yildiz","year":"2021","journal-title":"Am Hear J Plus"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/JICC.JICC_72_20","article-title":"Coronary slow flow\/no-reflow: revisited.","volume":"12","author":"Kanthallu","year":"2022","journal-title":"J Indian Coll Cardiol"},{"key":"R4-20250729","article-title":"Understanding the pathogenesis of coronary slow flow: recent advances.","author":"Zhu","year":"2022","journal-title":"Trends Cardiovasc Med"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0735-1097(00)00865-2","article-title":"Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction.","volume":"36","author":"Morishima","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.jacc.2009.12.054","article-title":"5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction.","volume":"55","author":"Ndrepepa","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2169\/internalmedicine.47.0884","article-title":"Predictors and long-term prognostic implications of angiographic slow\/no-flow during percutaneous coronary intervention for acute myocardial infarction.","volume":"47","author":"Suenari","year":"2008","journal-title":"Intern Med"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/MCA.0000000000000726","article-title":"Predictors and outcomes of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.","volume":"30","author":"Tasar","year":"2019","journal-title":"Coron Artery Dis"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5603\/MRJ.a2023.0024","article-title":"Coronary slow flow is not an adverse prognostic factor in MINOCA patients in the 5-year follow-up.","volume":"8","author":"Buller","year":"2023","journal-title":"Med. Res. J"},{"key":"R10-20250729","first-page":"202","article-title":"Long-term prognosis in patients with coronary slow flow.","volume":"17","author":"Mikaeilvand","year":"2022","journal-title":"J Tehran Heart Cent"},{"key":"R11-20250729","first-page":"236","article-title":"Persian Registry of cardioVascular diseasE (PROVE): design and methodology.","volume":"13","author":"Givi","year":"2017","journal-title":"ARYA Atheroscler"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2012.10.036","article-title":"Third universal definition of myocardial infarction.","volume":"46","author":"Jaffe","year":"2013","journal-title":"Clin Biochem"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM198504043121437","article-title":"The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings.","volume":"312","year":"1985","journal-title":"N Engl J Med"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.amjcard.2012.09.015","article-title":"Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction.","volume":"111","author":"Harrison","year":"2013","journal-title":"Am J Cardiol"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2019.07.067","article-title":"Clinical and procedural predictors and short-term survival of the patients with no reflow phenomenon after primary percutaneous coronary intervention.","volume":"294","author":"Ashraf","year":"2019","journal-title":"Int J Cardiol"},{"key":"R16-20250729","first-page":"30","article-title":"Predictors and prognosis of no-reflow during primary percutaneous coronary intervention. In: Baylor University Medical Center Proceedings.","author":"Nair Rajesh","year":"2018","journal-title":"Taylor & Francis"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.amjcard.2006.08.054","article-title":"Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality.","volume":"99","author":"Brosh","year":"2007","journal-title":"Am J Cardiol"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1067\/mhj.2003.36","article-title":"No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention.","volume":"145","author":"Resnic","year":"2003","journal-title":"Am Heart J"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0300-8932(07)75065-0","article-title":"Abnormal myocardial perfusion after infarction in patients with persistent TIMI grade-3 flow. Only an acute phenomenon?","volume":"60","author":"Bod\u00ed","year":"2007","journal-title":"Rev Esp Cardiol"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.amjcard.2011.09.037","article-title":"Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary intervention.","volume":"109","author":"Chan","year":"2012","journal-title":"Am J Cardiol"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/TCRM.S233512","article-title":"Incidence, predictors, and prognosis of coronary slow-flow and no-reflow phenomenon in patients with chronic total occlusion who underwent percutaneous coronary intervention.","volume":"16","author":"Wang","year":"2020","journal-title":"Ther Clin Risk Manag"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.12659\/MSM.906815","article-title":"Intracoronary nicorandil and the prevention of the no-reflow phenomenon during primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.","volume":"24","author":"Qi","year":"2018","journal-title":"Med Sci Monit"},{"key":"R23-20250729","first-page":"e2021297","article-title":"The no-reflow phenomenon: is it predictable by demographic factors and routine laboratory data?","volume":"92","author":"Namazi","year":"2021","journal-title":"Acta Bio Medica Atenei Parm"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/MCA.0000000000000848","article-title":"Predictive accuracy of lymphocyte-to-monocyte ratio and monocyte-to-high-density-lipoprotein-cholesterol ratio in determining the slow flow\/no-reflow phenomenon in patients with non-ST-elevated myocardial infarction.","volume":"31","author":"Kalyoncuoglu","year":"2020","journal-title":"Coron Artery Dis"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4103\/2211-4122.135615","article-title":"Assessment of no-reflow phenomenon by myocardial blush grade and pulsed wave tissue Doppler imaging in patients with acute coronary syndrome.","volume":"24","author":"Novo","year":"2014","journal-title":"J Cardiovasc Echogr"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T18:01:53Z","timestamp":1753812113000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,2]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001362","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,2]]}}}